Mayo Clinic
This is an observational study evaluating patients diagnosed with narcolepsy or idiopathic hypersomnia that have been prescribed a new/different hypersomnia treatment. The study is being done to better understand how hypersomnia treatment(s) impact blood pressure and cognitive function.
This is an observational study evaluating how hypersomnia medications influence blood pressure and cognitive function in patients diagnosed with narcolepsy or idiopathic hypersomnia. Blood pressure will be assessed using 24-hour ambulatory blood pressure monitoring equipment. Cognitive function will be evaluated using the Oculo-Cognitive Addition Test (OCAT). Both tests will performed at baseline (e.g., before starting a new hypersomnia medication) and after taking a stable dose of the new hypersomnia medication for at least three months. All medications will be prescribed by a clinical sleep…
Inclusion Criteria: * Diagnosed with narcolepsy or idiopathic hypersomnia according to International Classification of Sleep Disorders, third edition * Age 18 - 75 years * BMI between 18 and 40 kg/m2 * Prescribed a medication of interest (e.g., sodium oxybate, low sodium oxybate, pitolisant, modafinil/armodafinil, solriamfetol, traditional stimulant(s)) by a clinical sleep specialist as part of routine medical care. * Subject must be willing to postpone starting medication until after completion of baseline assessment(s). * If subject has been taking a prescribed hypersomnia medication(s) at…
Arm blood pressure cuff that will automatically inflate every 15-30 minutes to check blood pressure while awake and asleep over 24 hours. Patient will also complete a sleep diary and wear an actigraphy watch during this test.
Tracks users' eye movements as they complete a simple mental addition test.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.